Equity Clock

Arithmetic Average Seasonal Chart

Geometric Average Seasonal Chart

MTNB Relative to the S&P 500

MTNB Relative to the Sector

% of Free Cash Flow Generated in Each Quarter

% of Net Income Generated in Each Quarter

Seasonal Chart Analysis

Analysis of the Matinas BioPharma Holdings, Inc. (AMEX:MTNB) seasonal charts above shows that a Buy Date of August 14 and a Sell Date of January 9 has resulted in a geometric average return of 2.84% above the benchmark rate of the S&P 500 Total Return Index over the past 11 years. This seasonal timeframe has shown positive results compared to the benchmark in 7 of those periods. This is a fair rate of success and the return strongly outperforms the relative buy-and-hold performance of the stock over the past 11 years by an average of 39.57% per year.

The seasonal timeframe correlates Poorly with the period of seasonal strength for the Healthcare sector, which runs from April 25 to December 4. The seasonal chart for the broad sector is available via the following link: Healthcare Sector Seasonal Chart.

Matinas BioPharma Holdings, Inc. is a clinical-stage biopharmaceutical company. It engages in the business of delivering groundbreaking therapies using lipid nanocrystal platform delivery technology to maximize global clinical impact and patient access. The company was founded by Herbert J. Conrad and Jerome D. Jabbour in May 2013 and is headquartered in Bedminster, NJ.

To download MTNB seasonal chart data, please log in or Subscribe.

Stocks mentioned in this post: MTNB